Curis
CRIS
#11190
Rank
C$2.32 M
Marketcap
C$0.96
Share price
-5.38%
Change (1 day)
-55.05%
Change (1 year)

EPS for Curis (CRIS)

EPS in 2026 (TTM): C-$20.42

According to Curis's latest financial reports the company's current EPS (TTM) is C-$20.27. In 2025 the company made an earnings per share (EPS) of C-$33.94 an increase over its 2024 EPS that were of C-$200.41.

EPS history for Curis from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$20.42-39.82%
2025C-$33.94-83.07%
2024C-$200.41-22.15%
2023C-$257.43-26.17%
2022C-$348.6522.3%
2021C-$285.08-25.37%
2020C-$382.01-30.93%
2019C-$553.06-2.02%
2018C-$564.46
2016C-$1,283-10%
2015C-$1,425138.1%
2014C-$598.6740%
2013C-$427.62-25%
2012C-$570.1666.67%
2011C-$342.10

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.08-105.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
C$6.47-131.93%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
C-$0.51-97.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Exelixis
EXEL
C$4.70-123.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.20-69.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
C-$4.53-77.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
C-$4.90-75.81%๐Ÿ‡บ๐Ÿ‡ธ USA